FVALX
Price
$6.27
Change
-$0.00 (-0.00%)
Updated
Aug 21 closing price
Net Assets
3.54M
VIVIX
Price
$88.30
Change
+$0.49 (+0.56%)
Updated
Aug 21 closing price
Net Assets
256.41B
Interact to see
Advertisement

FVALX vs VIVIX

FVALX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
FVALX vs. VIVIX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVALX is a StrongBuy and VIVIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 256B vs. FVALX (3.54M). FVALX pays higher dividends than VIVIX: FVALX (2.04) vs VIVIX (1.86). FVALX was incepted earlier than VIVIX: FVALX (27 years) vs VIVIX (28 years). FVALX (1.27) is less costly to investors than VIVIX (0.03). FVALX is a more actively managed with annual turnover of: 32.04 vs. VIVIX (8.00). FVALX has a lower initial minimum investment than VIVIX: FVALX (1000) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 25.14 vs. FVALX (8.35). VIVIX return over 5 years is better than : 61.65 vs. FVALX (25.04).
FVALXVIVIXFVALX / VIVIX
Total Expense Ratio1.270.034,233%
Annual Report Gross Expense Ratio1.270.034,233%
Fund Existence27 years28 years-
Gain YTD5.20118.50828%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.54M256B0%
Annual Yield % from dividends2.041.86110%
Returns for 1 year8.3525.1433%
Returns for 3 years31.0460.5751%
Returns for 5 years25.0461.6541%
Returns for 10 years-34.87157.70-22%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHRAX95.851.11
+1.17%
ClearBridge Growth A
GSVRX17.540.08
+0.46%
Goldman Sachs Large Cap Value R
IYEFX12.610.05
+0.40%
Nomura Climate Solutions R
CADRX26.440.09
+0.34%
Columbia Large Cap Growth Opp Inst2
PRWCX38.840.05
+0.13%
T. Rowe Price Capital Appreciation